Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03525392
Recruitment Status : Terminated (Due to agreement to transfer rights for IPN01087 to an external partner, not due to safety concerns)
First Posted : May 15, 2018
Last Update Posted : June 7, 2021
Sponsor:
Information provided by (Responsible Party):
Ipsen

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : April 3, 2020
Actual Study Completion Date : April 28, 2021